Form 4 for ZVRA ZEVRA THERAPEUTICS, INC.
Accepted 2025-02-14 00:00:00 ET · period of report 2025-02-13 · accession 0001437749-25-004067 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-14 | 2025-02-13+ | ZVRA | McFarlane Neil F. | Pres, CEO, Dir | S - Sale | $7.92 | -91.8K | 222.1K | -29% | -$727.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-14 | S | D | 30,544 | $8.05 | 191,516 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-13 | S | D | 61,273 | $7.86 | 222,060 | D | — | — |